Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company that is developing innovative and proprietary treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions, today announced that Flex Pharma Co-founder and CEO, Christoph Westphal, M.D., Ph.D., has been appointed to the Biotechnology Industry Organization (BIO) Emerging Companies Section Governing Board. Dr. Westphal was Co-Founder, CEO and lead investor of Acceleron, Alnylam, Flex, Momenta, Sirtis and Verastem.
Help employers find you! Check out all the jobs and post your resume.
